Efficacy of different COVID-19 vaccines
Currently, various vaccines are available for COVID-19 from across the globe. People are debating on their efficacy and effectiveness.
In this context, know the efficacy of different types of COVID-19 vaccines:
The vaccine made by Pfizer showed an efficacy of 95% against various types of COVID-19 variants like B117, B1351, and P1. B117 was first detected in the UK, B1351 in South Africa, and P1 was detected in Brazil. The vaccine prevents the symptomatic COVID-19 infection in those who get two doses. Also, its protection is almost the same in different age groups, races, and ethnic groups.
Similar efficacy has shown by the Moderna vaccine. It has 94.1% effective in preventing the symptomatic COVID-19 infection after two doses. It is also effective against different types of COVID-19 variants like B117, B1351, and P1. However, the efficacy of the vaccine is slightly lower in people aged above 65 years. But, it offers similar protection to different racial and ethnic groups.
Covishield vaccine is effective against B117 and P1. However, it offers slightly lower protection against B1351. The vaccine offers protection by stimulating the immune system to generate antibodies to protect against COVID-19. Its overall efficacy is 70%.
Russia’s Sputnik offers 91% protection. As the clinical trials were majorly conducted in Russia, protection against various COVID-19 variants had not known.
Novavax, the 2-dose protein-based vaccine, has an efficacy of 89%. It offers enough protection against B117 and B1351.
Covaxin, the 2-dose inactivated virus vaccine, has overall efficacy of 78%. The vaccine stimulates the immune cells in the immune system to create antibodies as soon as it recognizes the dead virus. It also offers protection against B117.
The single-dose vaccine of Johnson and Johnson protects against all the above three variants, but not much protection against B1351 and P1. Its overall efficacy is 66%. Its efficacy differs with geographical locations. For instance, it showed 72% effectiveness in the USA, 60% in South America, and 57% efficacy in South Africa. It offers protection 28 days after the vaccination.
Image by torstensimon from Pixabay (Free for commercial use)
You may also like
Image Reference: https://pixabay.com/photos/vaccine-vaccination-covid-19-5926664/
Recent Posts
- BEL Project Engineer Recruitment 2025Joining BEL means working in an environment focused on innovation, skill development, and excellence.
- Jharkhand mandates QR codes on essential medicinesThe Jharkhand government has directed drug inspectors to increase market surveillance and conduct thorough inspections.
- CJI stresses presumption of constitutionality in Waqf Act challengeDuring the hearing of petitions against the recently passed Waqf Amendment Act, Chief Justice of India BR Gavai emphasised that laws cleared by Parliament are presumed constitutional unless a strong case is made to prove otherwise. The Supreme Court is currently examining key concerns, including the inclusion of non-Muslims in Waqf bodies and the identification of government land as Waqf property.
- BEL Project Engineer Recruitment 2025
What’s new at WeRIndia.com
News from 700+ sources
-
Zero tolerance for terrorism, India will never give in to nuclear blackmail: Jaishankar in Germany
-
Save up to $400 on three Navee e-scooters, like the 40-mile travelling S65 with dual suspension at $560 (Reg. $960)
-
DGP Review of Gun Licences in Telangana
-
You can skip the Ring: This 2K video doorbell is on sale and has no subscription fees
-
D-Wave revives ‘quantum supremacy’ claims for new Advantage2 computer
-
Em Arlott makes up for lost time as England romp to nine-wicket rout
-
WeRIndia – A News Aggregator
Visit werindia.com for all types of National | Business | World | Politics | Entertainment | Health related news and much more..